Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01676259
Title A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer (PROTACT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Silenseed Ltd
Indications

pancreatic cancer

Therapies

Gemcitabine + Nab-paclitaxel + siG12D-LODER

Gemcitabine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hackensack Meridian Health Active, not recruiting Hackensack New Jersey 07601 United States Details
The Mount Sinai Hospital Recruiting New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Rambam Medical Center Recruiting Haifa 3525408 Israel Details
Rabin Medical Center Completed Petah Tikva 49102 Israel Details
Sheba Medical Center (Tel H'shomer) Recruiting Ramat Gan 52621 Israel Details
Sourasky MC (Ichilov) Tel Aviv Israel Recruiting Tel Aviv Israel Details
Assaf Harofeh Medical Center Active, not recruiting Tzrifin 70300 Israel Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field